Sprint Quattro Secure S MRI SureScan 6935M
Sprint Quattro Family of Leads Indications Medtronic Sprint Quattro leads are intended for pacing and sensing and/ or defibrillation. Defibrillation leads have application for patients for whom implantable cardioverter defibrillation is indicated. The Sprint Quattro MRI SureScan Leads (which include specified lengths of Models 6935, 6935M, 6947 and 6947M) are part of a Medtronic SureScan ICD or CRT-D system. Consult individual lead model technical manuals for more detail. A complete SureScan defibrillation or CRT-D system is required for use in the MR environment and includes a Medtronic SureScan device connected to Medtronic SureScan Leads. Contraindications The Sprint Quattro leads are contraindicated:
- For the sole use of detection and treatment of atrial arrhythmias
- In patients with tricuspid valvular disease and/or patients with mechanical tricuspid heart valves
- For patients with transient ventricular tachyarrythmias due to reversible causes (drug intoxication, electrolyte imbalance, sepsis, hypoxia) or other factors (myocardial infarction, electric shock)
- In patients for whom a single dose of 1.0 mg of dexamethasone acetate and dexamethasone sodium phosphate may be contraindicated
Brand new products! Fast delivery!
Return Policy
Items are sold as-is with no returns or refunds available unless explicitly stated.